» Articles » PMID: 32823938

Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department

Overview
Journal J Clin Med
Specialty General Medicine
Date 2020 Aug 23
PMID 32823938
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Some 20% of patients with stable Chronic Obstructive Pulmonary Disease (COPD) might have heart failure (HF). HF contribution to acute exacerbations of COPD (AECOPD) presenting to the emergency department (ED) is not well established.

Aims: To assess (1) the HF incidence in patients presenting to the ED with AECOPD; (2) the concordance between ED and respiratory ward (RW) diagnosis; (3) the factors associated with risk of death after hospital discharge.

Methods: Retrospective chart review of 119 COPD patients presenting to ED for acute exacerbation of respiratory symptoms and then admitted to RW where a final diagnosis of AECOPD, AECOPD and HF and AECOPD and OD (other diagnosis), was obtained. ED and RW diagnosis were then compared. Factors affecting survival at follow-up were investigated.

Results: At RW, 40.3% of cases were diagnosed of AECOPD, 40.3% of AECOPD and HF and 19.4% of AECOPD and OD, with ED diagnosis coinciding with RW's in 67%, 23%, and 57% of cases respectively. At RW, 60% of patients in GOLD1 had HF, of which 43% were diagnosed at ED, while 40% in GOLD4 had HF that was never diagnosed at ED. Lack of inclusion in a COPD care program, HF, and early readmission for AECOPD were associated with mortality.

Conclusions: HF is highly prevalent and difficult to diagnose in patients in all GOLD stages presenting to the ED with severe AECOPD, and along with lack of inclusion in a COPD care program, confers a high risk for mortality.

Citing Articles

An enhanced machine learning-based prognostic prediction model for patients with AECOPD on invasive mechanical ventilation.

Fu Y, Liu Y, Zhong C, Heidari A, Liu L, Yu S iScience. 2024; 27(12):111230.

PMID: 39640592 PMC: 11617955. DOI: 10.1016/j.isci.2024.111230.


Value of Lung Ultrasound Sonography B-Lines Quantification as a Marker of Heart Failure in COPD Exacerbation.

Lajili F, Toumia M, Sekma A, Ali K, Sassi S, Zorgati A Int J Chron Obstruct Pulmon Dis. 2024; 19:1767-1774.

PMID: 39108664 PMC: 11300558. DOI: 10.2147/COPD.S447819.


Lack of Evidence Regarding Markers Identifying Acute Heart Failure in Patients with COPD: An AI-Supported Systematic Review.

van Dijk S, Brusse-Keizer M, Bucsan C, Ploumen E, van Beurden W, van der Palen J Int J Chron Obstruct Pulmon Dis. 2024; 19:531-541.

PMID: 38414719 PMC: 10898598. DOI: 10.2147/COPD.S437899.


Exploring Patterns of COPD Exacerbations and Comorbid Flare-Ups.

van Dijk S, Brusse-Keizer M, Effing T, van der Valk P, Ploumen E, van der Palen J Int J Chron Obstruct Pulmon Dis. 2023; 18:2633-2644.

PMID: 38022827 PMC: 10657781. DOI: 10.2147/COPD.S428960.


Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.

Swart K, Baak B, Lemmens L, Penning-van Beest F, Bengtsson C, Lobier M Respir Res. 2023; 24(1):293.

PMID: 37990197 PMC: 10662240. DOI: 10.1186/s12931-023-02601-4.


References
1.
Matamis D, Tsagourias M, Papathanasiou A, Sineffaki H, Lepida D, Galiatsou E . Targeting occult heart failure in intensive care unit patients with acute chronic obstructive pulmonary disease exacerbation: effect on outcome and quality of life. J Crit Care. 2013; 29(2):315.e7-14. DOI: 10.1016/j.jcrc.2013.11.011. View

2.
Boussuges A, Pinet C, Molenat F, Burnet H, Ambrosi P, Badier M . Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study. Am J Respir Crit Care Med. 2000; 162(2 Pt 1):670-5. DOI: 10.1164/ajrccm.162.2.9908056. View

3.
Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T . Fatal adverse drug events: the paradox of drug treatment. J Intern Med. 2001; 250(4):327-41. DOI: 10.1046/j.1365-2796.2001.00892.x. View

4.
Au D, Udris E, Fan V, Curtis J, McDonell M, Fihn S . Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. Chest. 2003; 123(6):1964-9. DOI: 10.1378/chest.123.6.1964. View

5.
Hangaard S, Helle T, Nielsen C, Hejlesen O . Causes of misdiagnosis of chronic obstructive pulmonary disease: A systematic scoping review. Respir Med. 2017; 129:63-84. DOI: 10.1016/j.rmed.2017.05.015. View